Empov - Aprepitent 125/80 mg Caps

Empov 125/80 mg contains aprepitant, an antiemetic medication belonging to the neurokinin-1 (NK1) receptor antagonist class. It is used primarily to help prevent chemotherapy-induced nausea and vomiting, particularly delayed nausea and vomiting that may occur after cancer treatment. Aprepitant works by blocking substance P activity at NK1 receptors in the brain, helping control the pathways responsible for nausea and vomiting. It is commonly incorporated into combination antiemetic regimens alongside other medicines to provide comprehensive symptom prevention. The dosage and treatment schedule are selected according to the chemotherapy regimen and established clinical protocols.